PATENT CLAIM ANALYSIS

Application Number: 15969383
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["546", "273700"]

Abstract:
The present invention relates to a process for the preparation of anhydrous crystalline 2-(R)-[(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl]-1H-benzimidazole (dexlansoprazole).

Claim (Index 16):
A crystalline anhydrous dexlansoprazole characterized by an XRPD pattern having peaks at 7.5, 11.4, 13.1, 13.5, 15.1, 15.4, 17.3, 20.0, 21.7, 22.5, 24.0, 26.1, 27.3 and 28.6\u00b10.2\u00b0 in 2\u03b8, produced by a process comprising dispersing dexlansoprazole in one or more C 5 -C 9  alkanes or in a mixture comprising one or more C 5 -C 9  alkanes and one or more C 1 -C 6  alcohols, at a temperature of up to 50\u00b0 C.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12830713', '15501908', '12693539', '12356004', '12283702']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7586149728703485
- 35 USC 102 Novelty (BERT): 0.5674617658270901
- Combined Prediction Score: 0.7394996521660226
- Mean Citation Score: 264.91933400000005
- Max Citation Score: 486.37616
- Similarity Product: 368.6046331378652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test